These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19774499)

  • 1. Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas.
    Wang EL; Qian ZR; Yamada S; Rahman MM; Inosita N; Kageji T; Endo H; Kudo E; Sano T
    Endocr Pathol; 2009; 20(4):209-20. PubMed ID: 19774499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
    Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
    Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GATA-2 in human pituitary adenomas.
    Umeoka K; Sanno N; Osamura RY; Teramoto A
    Mod Pathol; 2002 Jan; 15(1):11-7. PubMed ID: 11796836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.
    Nielsen S; Mellemkjaer S; Rasmussen LM; Ledet T; Olsen N; Bojsen-Møller M; Astrup J; Weeke J; Jørgensen JO
    J Endocrinol Invest; 2001 Jun; 24(6):430-7. PubMed ID: 11434667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
    Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A
    World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas.
    Sanno N; Teramoto A; Matsuno A; Itoh J; Takekoshi S; Osamura RY
    Acta Neuropathol; 1996; 91(3):263-8. PubMed ID: 8834538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
    Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
    Horiguchi K; Yamada M; Umezawa R; Satoh T; Hashimoto K; Tosaka M; Yamada S; Mori M
    Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
    Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
    Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas.
    Astaf'eva LI; Kadashev BA; Shishkina LV; Kalinin PL; Fomichev DV; Kutin MA; Aref'eva IA; Dzeranova LK; Sidneva YG; Klochkova IS; Rotin DL
    Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(6):24-35. PubMed ID: 28139570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
    Umeoka K; Sanno N; Oyama K; Tahara S; Kurotani R; Ikuyama S; Nakashima M; Watanabe T; Osamura RY; Teramoto A
    Mod Pathol; 2001 Dec; 14(12):1232-6. PubMed ID: 11743045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: special reference to gonadotropin-positive adenomas.
    Sano T; Yamada S
    Pathol Int; 1994 Sep; 44(9):697-703. PubMed ID: 7804432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence.
    Kirkman MA; Jaunmuktane Z; Brandner S; Khan AA; Powell M; Baldeweg SE
    World Neurosurg; 2014 Dec; 82(6):1224-31. PubMed ID: 24657816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor profile in pituitary thyrotroph adenomas.
    Thodou E; Kontogeorgos G
    Clin Neurol Neurosurg; 2020 Aug; 195():105865. PubMed ID: 32416325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of clinically silent thyrotropin pituitary adenomas: A single center series of 20 patients.
    Cyprich J; Donoho DA; Brunswick A; Hurth K; Carmichael JD; Weiss MH; Zada G
    J Clin Neurosci; 2020 Jan; 71():70-75. PubMed ID: 31668712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Silent" thyrotropin (TSH) expression in acromegaly and clinically non-functioning pituitary adenomas.
    Pawlikowski M; Pisarek H; Jaranowska M; Radek M; Winczyk K; Kunert-Radek J
    Endokrynol Pol; 2016; 67(5):515-518. PubMed ID: 27403655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.